Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension?
Messerli
Franz H
FH
Bangalore
Sripal
S
Egan
Brent M
BM
Julius
Stevo
S
D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use; D001713:Biphenyl Compounds; D008078:Cholesterol, LDL / Q000097:blood* / Q000187:drug effects; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications*; D006973:Hypertension / Q000517:prevention & control*; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D008078:Cholesterol, LDL; D013777:Tetrazoles; C081643:candesartan